Europe Market Report for Ultrasonic Devices 2017 - MedCore
General Report Contents
Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
Market Drivers & Limiters for each chapter segment
Competitive Analysis for each chapter segment
Section on recent mergers & acquisitions
Ultrasonic energy ensures that no electrical energy is being transmitted to the patient, which is associated with ulceration, incidental thermal damage to organs and other clinical problems. Therefore, ultrasonic energy provides a safer method for cutting and coagulating during laparoscopic surgeries. Large hospitals that frequently perform laparoscopic surgeries are more able to purchase ultrasonic instruments. With larger contracts signed for instruments, hospitals often negotiate and receive complimentary ultrasonic hardware from manufacturers.
This market is divided into reusable and reposable products. Reusable ultrasonic devices refer to devices that are completely reusable, whereas reposable refers to devices that have both a reusable and a disposable component. Currently, only Olympus makes a fully reusable ultrasonic device, the SonoSurg™, while there are a number of major manufacturers in the reposable ultrasonic market.
Ultrasonic devices utilize ultrasonic energy to cut and coagulate tissue. They can complement or replace vessel ligators, hemostatic clips and monopolar electrosurgical instruments. In contrast to devices such as lasers or electrocautery instruments that use heat from electrical energy to cauterize tissue, ultrasonic instruments convert electrical energy to mechanical energy in order to transect tissue. This conversion results in less charred tissue than in operations that utilize monopolar dissection. Less smoke from reduced tissue charring also benefits surgeons by providing them with a clearer view of the operative field. Depending on the indication, ultrasonic devices have quicker cutting times and better vessel sealing capabilities than their direct energy counterparts.